Abiopharma

Midland States Bancorp, Inc. receives expected notification of deficiency from Nasdaq related to delayed filing of Quarterly Report on Form 10-Q

New Form 8-K - Protalix BioTherapeutics, Inc. Filed: 2025-08-22 AccNo: 0001104659-25-081924 Size: 234 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits

New Form 144 - Wave Life Sciences Ltd. Filed: 2025-08-22 AccNo: 0001950047-25-006240 Size: 5 KB

BOYER ANDREW S 🟡 adjusted position in 279.2K shares (1 derivative) of Amneal Pharmaceuticals, Inc. (AMRX) at $9.38 ($3.6M) Transaction Date: Aug 20, 2025 | Filing ID: 041033

New Form 144 - THERMO FISHER SCIENTIFIC INC. Filed: 2025-08-22 AccNo: 0001959173-25-005477 Size: 6 KB

UTHR: Notification

New Form SCHEDULE 13D/A - STAR EQUITY HOLDINGS, INC. Filed: 2025-08-22 AccNo: 0001548312-25-000004 Size: 8 KB

New Form 3 - ECOLAB INC. Filed: 2025-08-22 AccNo: 0001415889-25-022763 Size: 25 KB

New Form S-8 - SANUWAVE Health, Inc. Filed: 2025-08-22 AccNo: 0001628280-25-041027 Size: 794 KB

MAHON PAUL A 🟡 adjusted position in 11.0K shares (1 derivative) of UNITED THERAPEUTICS Corp (UTHR) at $310.25 ($6.4M) Transaction Date: Aug 21, 2025 | Filing ID: 005953

New Form 424B5 - Protalix BioTherapeutics, Inc. Filed: 2025-08-22 AccNo: 0001104659-25-081913 Size: 371 KB

New Form 8-K - STRATA Skin Sciences, Inc. Filed: 2025-08-22 AccNo: 0001140361-25-032373 Size: 161 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

O'sullivan Paul Jason 🟢 acquired 20.0K shares of REGIONAL HEALTH PROPERTIES, INC (RHEP) at $1.92 Transaction Date: Aug 18, 2025 | Filing ID: 025228

Scott Kathleen D. 🟡 adjusted position in 12.5K shares (1 derivative) of ARS Pharmaceuticals, Inc. (SPRY) at $15.00 Transaction Date: Aug 21, 2025 | Filing ID: 022760

dMY Squared Technology Group, Inc. Receives NYSE American Notice Regarding Delayed Form 10-Q Filing